SARS-CoV-2 antibody prevalence by industry, workplace characteristics, and workplace infection prevention and control measures, North Carolina, 2021 to 2022.

Carolyn Gigot Nora PisanicKristoffer SpicerMeghan F DavisKate KruczynskiMagdielis Gregory RiveraKirsten KoehlerD J HallDevon J HallChristopher D Heaney

Published in: medRxiv : the preprint server for health sciences (2024)

This study contributes evidence of the severe and disproportionate impacts of COVID-19 on animal processing and essential workers and workers in large congregate settings. We also demonstrate the utility of combining non-invasive biomarker and questionnaire data for the study of workplace exposures.

Keyphrases

sars cov
coronavirus disease
risk factors
early onset
patient reported